Documente Academic
Documente Profesional
Documente Cultură
Drugs: ANTIBIOTICS
Presented by:
Flores, Lanie Grace P.
Gongora, Erica Mae S.
W
I
S
AMINOGLYCOSIDES
Group of chemically related antibiotics
Treatment of infections with Gram () bacteria that are
resistant to less toxic antibiotics
Act synergistically against certain Gram (+) organisms
Used in treatment of:
Severe infections of abdomen and UT
Bacteremia
Endocarditis
ROUTES OF
ADMINISTRATION
Not well absorbed from the GI tract,
it is limited to:
Intravenous (IV)
Intramuscular (IM)
GENTAMICIN
Most commonly used
Low cost
Reliable activity against Gram (-)
aerobes
TOBRAMYCIN
Has greater in vitro activity against
Pseudomonas aeruginosa
AMIKACIN
Effective against resistant organisms
Its chemical structure makes it less
susceptible to inactivating enzymes
KANAMYCIN
Used to treat serious bacterial
infections in many different parts of
the body
Short-term use only
Toxic effects more likely to occur in
elderly patients and newborn infants
STREPTOMYCIN
The first aminoglycoside
Isolated from Streptomyces griseus
Used for:
Tuberculosis
Infections caused by certain bacteria
NEOMYCIN
Had better activity than
Streptomycin against aerobic Gram
(-) bacilli
Could not safely be used systemically
due to its formidable toxicity
Isolated from Streptomyces fradiae
TOXIC EFFECTS
Ototoxic effect
Disrupts inner ear cochlear and vestibular
membrane
o Hearing and balance impairment
o Irreversible
Nephrotoxic effect
Increase in serum creatinine and BUN
Impairs the function of the PCT
o Electrolyte imbalance
o Possibly proteinuria
TOXIC EFFECTS
Neuromuscular blockade
Administration of neuromuscular blocking
drugs and anesthetics
Hypocalcemia
Myasthenia gravis
Hypersensitivity reactions
Superinfections
CNS effects
GI disturbances
ELIMINATION
Renal filtration
Patients with compromised renal
function, adjustments must be made
based on serum concentration
METHODS
Chromatography
Immunoassay
VANCOMYCIN
Glycopeptide antibiotic
Effective against Gram (+) cocci and bacilli
Skipping doses may increase risk of further
infection that is resistant to antibiotics
Used against resistant strains of
Streptococcus and Staphylococcus
Only trough levels are monitored to ensure
the serum drug concentration is within the
therapeutic range
ROUTE OF ADMINISTRATION
Because of poor oral absorption, it is
administered by:
IV infusion
TOXIC EFFECTS
Red-man syndrome
Erythemic flushing of the extremities
ELIMINATION
Renal filtration
Excretion
METHODS
Chromatography
Immunoassay
CHLORAMPHENICOL
ROUTES OF
ADMINISTRATION
Well absorbed orally
Intravenous (IV)
TOXIC EFFECTS
Blood dyscrasia
Gray baby syndrome
Condition that occurs in newborns
(especially premature babies) who are
given the drug chloramphenicol
Cytoplasmic vacuolation
Erythroid cells
Myeloid cells
ELIMINATION
68%-99%
Excreted in the urine
8% - 12%
Excreted as free chloramphenicol
REFERENCES:
Bishop, Michael (2010). Clinical Chemistry 6th Edition: Techniques, Principles,
Correlations.
Rodriguez, M.T. (2014). Clinical Chemistry Review Handbook for Medical
Technologists.
Tortora et al. (1998). Microbiology: An Introduction 6th Edition.
http://www.aafp.org/afp/1998/1115/p1811.html
http://www.drugs.com/cdi/streptomycin.html
http://campus.usal.es/~galenica/clinpkin/Aminoglycosides.htm
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a604038.html
https://www.merckmanuals.com/professional/infectious-diseases/bacteria-and-antib
acterial-drugs/chloramphenicol
http://www.medicinenet.com/chloramphenicol-oral/article.htm